vs

Side-by-side financial comparison of Karat Packaging Inc. (KRT) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($225.6M vs $115.6M, roughly 2.0× Karat Packaging Inc.). Organogenesis Holdings Inc. runs the higher net margin — 19.4% vs 5.9%, a 13.5% gap on every dollar of revenue. On growth, Organogenesis Holdings Inc. posted the faster year-over-year revenue change (78.1% vs 13.7%). Organogenesis Holdings Inc. produced more free cash flow last quarter ($34.8M vs $15.1M). Over the past eight quarters, Organogenesis Holdings Inc.'s revenue compounded faster (43.2% CAGR vs 10.0%).

Karat Packaging Inc. is a specialty manufacturer and distributor of disposable foodservice packaging products. Its offerings include paper and plastic cups, food containers, cutlery, lids, and custom branded solutions, serving restaurant chains, cafes, catering operators, and retail foodservice clients primarily across North America.

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

KRT vs ORGO — Head-to-Head

Bigger by revenue
ORGO
ORGO
2.0× larger
ORGO
$225.6M
$115.6M
KRT
Growing faster (revenue YoY)
ORGO
ORGO
+64.4% gap
ORGO
78.1%
13.7%
KRT
Higher net margin
ORGO
ORGO
13.5% more per $
ORGO
19.4%
5.9%
KRT
More free cash flow
ORGO
ORGO
$19.6M more FCF
ORGO
$34.8M
$15.1M
KRT
Faster 2-yr revenue CAGR
ORGO
ORGO
Annualised
ORGO
43.2%
10.0%
KRT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
KRT
KRT
ORGO
ORGO
Revenue
$115.6M
$225.6M
Net Profit
$6.8M
$43.7M
Gross Margin
34.0%
Operating Margin
7.3%
28.1%
Net Margin
5.9%
19.4%
Revenue YoY
13.7%
78.1%
Net Profit YoY
21.3%
469.5%
EPS (diluted)
$0.34
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KRT
KRT
ORGO
ORGO
Q4 25
$115.6M
$225.6M
Q3 25
$124.5M
$150.9M
Q2 25
$124.0M
$101.0M
Q1 25
$103.6M
$86.7M
Q4 24
$101.6M
$126.7M
Q3 24
$112.8M
$115.2M
Q2 24
$112.6M
$130.2M
Q1 24
$95.6M
$110.0M
Net Profit
KRT
KRT
ORGO
ORGO
Q4 25
$6.8M
$43.7M
Q3 25
$7.3M
$21.6M
Q2 25
$10.9M
$-9.4M
Q1 25
$6.4M
$-18.8M
Q4 24
$5.6M
$7.7M
Q3 24
$9.1M
$12.3M
Q2 24
$9.1M
$-17.0M
Q1 24
$6.2M
$-2.1M
Gross Margin
KRT
KRT
ORGO
ORGO
Q4 25
34.0%
Q3 25
34.5%
Q2 25
39.6%
Q1 25
39.3%
72.6%
Q4 24
39.2%
75.5%
Q3 24
38.6%
76.7%
Q2 24
38.5%
77.6%
Q1 24
39.3%
73.9%
Operating Margin
KRT
KRT
ORGO
ORGO
Q4 25
7.3%
28.1%
Q3 25
6.9%
13.7%
Q2 25
13.3%
-12.5%
Q1 25
7.5%
-30.9%
Q4 24
7.2%
8.1%
Q3 24
10.0%
5.4%
Q2 24
9.9%
-10.7%
Q1 24
8.4%
-3.5%
Net Margin
KRT
KRT
ORGO
ORGO
Q4 25
5.9%
19.4%
Q3 25
5.9%
14.3%
Q2 25
8.8%
-9.3%
Q1 25
6.2%
-21.7%
Q4 24
5.5%
6.1%
Q3 24
8.1%
10.7%
Q2 24
8.1%
-13.1%
Q1 24
6.4%
-1.9%
EPS (diluted)
KRT
KRT
ORGO
ORGO
Q4 25
$0.34
$0.31
Q3 25
$0.36
$0.11
Q2 25
$0.54
$-0.10
Q1 25
$0.32
$-0.17
Q4 24
$0.28
$0.05
Q3 24
$0.45
$0.09
Q2 24
$0.45
$-0.13
Q1 24
$0.31
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KRT
KRT
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$37.9M
$93.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$149.4M
$300.1M
Total Assets
$287.7M
$598.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KRT
KRT
ORGO
ORGO
Q4 25
$37.9M
$93.7M
Q3 25
$44.0M
$63.7M
Q2 25
$57.0M
$73.1M
Q1 25
$56.3M
$110.0M
Q4 24
$59.9M
$135.6M
Q3 24
$60.4M
$94.3M
Q2 24
$52.1M
$89.9M
Q1 24
$46.7M
$88.6M
Total Debt
KRT
KRT
ORGO
ORGO
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$62.3M
Q2 24
$63.8M
Q1 24
$65.2M
Stockholders' Equity
KRT
KRT
ORGO
ORGO
Q4 25
$149.4M
$300.1M
Q3 25
$154.5M
$255.1M
Q2 25
$155.8M
$233.2M
Q1 25
$153.3M
$242.9M
Q4 24
$155.6M
$262.9M
Q3 24
$157.3M
$278.5M
Q2 24
$157.7M
$263.5M
Q1 24
$154.4M
$278.0M
Total Assets
KRT
KRT
ORGO
ORGO
Q4 25
$287.7M
$598.7M
Q3 25
$302.8M
$509.8M
Q2 25
$321.0M
$461.1M
Q1 25
$312.2M
$467.4M
Q4 24
$294.5M
$497.9M
Q3 24
$306.8M
$446.3M
Q2 24
$310.7M
$443.2M
Q1 24
$279.0M
$458.5M
Debt / Equity
KRT
KRT
ORGO
ORGO
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.22×
Q2 24
0.24×
Q1 24
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KRT
KRT
ORGO
ORGO
Operating Cash FlowLast quarter
$15.4M
$39.4M
Free Cash FlowOCF − Capex
$15.1M
$34.8M
FCF MarginFCF / Revenue
13.1%
15.4%
Capex IntensityCapex / Revenue
0.2%
2.1%
Cash ConversionOCF / Net Profit
2.26×
0.90×
TTM Free Cash FlowTrailing 4 quarters
$33.1M
$-24.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KRT
KRT
ORGO
ORGO
Q4 25
$15.4M
$39.4M
Q3 25
$982.0K
$3.1M
Q2 25
$9.8M
$-32.9M
Q1 25
$7.7M
$-19.9M
Q4 24
$8.3M
$10.9M
Q3 24
$19.5M
$8.7M
Q2 24
$13.7M
$4.7M
Q1 24
$6.6M
$-10.2M
Free Cash Flow
KRT
KRT
ORGO
ORGO
Q4 25
$15.1M
$34.8M
Q3 25
$736.0K
$844.0K
Q2 25
$9.6M
$-36.5M
Q1 25
$7.6M
$-23.6M
Q4 24
$8.0M
$7.6M
Q3 24
$19.2M
$6.1M
Q2 24
$13.4M
$2.9M
Q1 24
$6.4M
$-12.4M
FCF Margin
KRT
KRT
ORGO
ORGO
Q4 25
13.1%
15.4%
Q3 25
0.6%
0.6%
Q2 25
7.7%
-36.1%
Q1 25
7.4%
-27.2%
Q4 24
7.9%
6.0%
Q3 24
17.0%
5.3%
Q2 24
11.9%
2.2%
Q1 24
6.7%
-11.3%
Capex Intensity
KRT
KRT
ORGO
ORGO
Q4 25
0.2%
2.1%
Q3 25
0.2%
1.5%
Q2 25
0.1%
3.6%
Q1 25
0.1%
4.2%
Q4 24
0.2%
2.7%
Q3 24
0.3%
2.2%
Q2 24
0.2%
1.4%
Q1 24
0.2%
2.0%
Cash Conversion
KRT
KRT
ORGO
ORGO
Q4 25
2.26×
0.90×
Q3 25
0.13×
0.14×
Q2 25
0.89×
Q1 25
1.21×
Q4 24
1.47×
1.43×
Q3 24
2.14×
0.71×
Q2 24
1.50×
Q1 24
1.06×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons